Yubo International Biotech Limited (YBGJ)

OTCMKTS · Delayed Price · Currency is USD
0.0115
+0.0011 (10.58%)
Mar 6, 2026, 4:00 PM EST
-83.11%
Market Cap 1.77M
Revenue (ttm) -18.00
Net Income (ttm) -1.11M
Shares Out 170.42M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 147,053
Open 0.0115
Previous Close 0.0104
Day's Range 0.0115 - 0.0115
52-Week Range 0.0079 - 0.1776
Beta 0.90
RSI 36.48
Earnings Date Mar 31, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China. [Read more]

Sector Healthcare
CEO Yang Wang
Employees 18
Stock Exchange OTCMKTS
Ticker Symbol YBGJ
Full Company Profile

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.

Financial Statements

News

There is no news available yet.